| No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
| 1 |
rs1186380 |
chr12:121376416-121376417 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
| 2 |
rs544219171 |
chr12:121376531-121376532 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 3 |
rs557681817 |
chr12:121376638-121376639 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 4 |
rs140202929 |
chr12:121376651-121376652 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 5 |
rs188631234 |
chr12:121376667-121376668 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 6 |
rs377103563 |
chr12:121376672-121376673 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 7 |
rs540508356 |
chr12:121376714-121376715 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 8 |
rs574819080 |
chr12:121376743-121376744 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 9 |
rs560133033 |
chr12:121376749-121376750 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 10 |
rs529065909 |
chr12:121376771-121376772 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 11 |
rs540697143 |
chr12:121376806-121376807 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 12 |
rs149640834 |
chr12:121376809-121376810 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 13 |
rs375371363 |
chr12:121376826-121376827 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 14 |
rs560582182 |
chr12:121376894-121376895 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 15 |
rs577470912 |
chr12:121376994-121376995 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 16 |
rs192801505 |
chr12:121377013-121377014 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 17 |
rs183188850 |
chr12:121377057-121377058 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 18 |
rs146139730 |
chr12:121377087-121377088 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 19 |
rs187717914 |
chr12:121377124-121377125 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 20 |
rs11835269 |
chr12:121377143-121377144 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 21 |
rs555368593 |
chr12:121377185-121377186 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 22 |
rs11065353 |
chr12:121377210-121377211 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 23 |
rs555511910 |
chr12:121377246-121377247 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 24 |
rs569010909 |
chr12:121377315-121377316 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 25 |
rs10849821 |
chr12:121377329-121377330 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 26 |
rs140136377 |
chr12:121377352-121377353 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 27 |
rs566162492 |
chr12:121377362-121377363 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 28 |
rs561751146 |
chr12:121377383-121377384 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 29 |
rs111638450 |
chr12:121377398-121377399 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 30 |
rs540188501 |
chr12:121377471-121377472 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 31 |
rs10849822 |
chr12:121377494-121377495 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 32 |
rs547050340 |
chr12:121377551-121377552 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 33 |
rs78197988 |
chr12:121377567-121377568 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 34 |
rs542867742 |
chr12:121377606-121377607 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 35 |
rs539247143 |
chr12:121377642-121377643 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 36 |
rs7969196 |
chr12:121377656-121377657 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 37 |
rs531445331 |
chr12:121377660-121377661 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 38 |
rs191491852 |
chr12:121377704-121377705 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 39 |
rs370169813 |
chr12:121377785-121377786 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 40 |
rs199813892 |
chr12:121377846-121377847 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 41 |
rs367937719 |
chr12:121377847-121377848 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 42 |
rs564919879 |
chr12:121377860-121377861 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 43 |
rs527343073 |
chr12:121377874-121377875 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 44 |
rs527263459 |
chr12:121377899-121377900 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 45 |
rs374583644 |
chr12:121377908-121377909 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 46 |
rs534847496 |
chr12:121377929-121377930 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 47 |
rs553892112 |
chr12:121377962-121377963 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 48 |
rs547043337 |
chr12:121377980-121377981 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 49 |
rs560861334 |
chr12:121378036-121378037 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 50 |
rs535771408 |
chr12:121378046-121378047 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|